|
September 18, 2023
|
Histogen Announces Board Approval of Complete Liquidation and Dissolution
|
|
|
July 5, 2023
|
Histogen to Explore Strategic Alternatives
|
|
|
May 11, 2023
|
Histogen Reports First Quarter 2023 Results and Provides Business Update
|
|
|
April 20, 2023
|
Histogen Announces Online Publication in the Journal of Investigative Dermatology
|
|
|
April 3, 2023
|
Histogen Announces Exclusive Intellectual Property License Agreement with Johns Hopkins University
|
|
|
March 16, 2023
|
Histogen Announces Issuance of US Patent Covering CTS-2090 Methods of Use
|
|
|
March 9, 2023
|
Histogen Reports Year-End 2022 Results and Provides Business Update
|
|
|
February 27, 2023
|
Histogen Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
|
|
|
January 3, 2023
|
Histogen Hires Alfred P. Spada Ph.D. as Executive Vice President and Chief Scientific Officer
|
|
